Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Liabilities from Discontinued Operations (2017 - 2023)

Historic Liabilities from Discontinued Operations for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 6 years, with Q1 2023 value amounting to $518000.0.

  • Lifecore Biomedical, Inc. \De\'s Liabilities from Discontinued Operations fell 9410.69% to $518000.0 in Q1 2023 from the same period last year, while for Feb 2023 it was $518000.0, marking a year-over-year decrease of 9410.69%. This contributed to the annual value of $4.7 million for FY2022, which is 9040.78% down from last year.
  • Per Lifecore Biomedical, Inc. \De\'s latest filing, its Liabilities from Discontinued Operations stood at $518000.0 for Q1 2023, which was down 9410.69% from $16.8 million recorded in Q4 2022.
  • Lifecore Biomedical, Inc. \De\'s Liabilities from Discontinued Operations' 5-year high stood at $66.5 million during Q4 2020, with a 5-year trough of $518000.0 in Q1 2023.
  • Moreover, its 4-year median value for Liabilities from Discontinued Operations was $49.5 million (2021), whereas its average is $35.4 million.
  • In the last 5 years, Lifecore Biomedical, Inc. \De\'s Liabilities from Discontinued Operations plummeted by 607.64% in 2021 and then crashed by 9410.69% in 2023.
  • Lifecore Biomedical, Inc. \De\'s Liabilities from Discontinued Operations (Quarter) stood at $66.5 million in 2020, then decreased by 6.08% to $62.4 million in 2021, then crashed by 73.03% to $16.8 million in 2022, then plummeted by 96.92% to $518000.0 in 2023.
  • Its last three reported values are $518000.0 in Q1 2023, $16.8 million for Q4 2022, and $8.8 million during Q3 2022.